Before you visit the exhibit hall at an annual conference or scientific session, how much planning do you do?

• Before you visit the exhibit hall at an annual conference or scientific session, how much planning do you do?
  

I arrive with a list of whom I will meet and which exhibits I will visit.

I have an idea of whom I will meet and what exhibits I will visit, but I want to see what else catches my attention.

I have no plan beyond finding out which exhibits are interesting.

Sign up today to have the latest news in drug development worldwide delivered to your inbox ~ DIA's Global Smartbrief.

Deadline approaching for Life Science Entrepreneur/Start Up Application | DIA 2012: Collaborate to Innovate | Deadline: Monday, April 16, 2012

DEADLINE TO APPLY - April 16, 2012

DIA 2012 Collaborate to Innovate

48th Annual Meeting
June 24-28, 2012
Philadelphia, PA
Pennsylvania Convention Center

DIA 2012: Collaborate to Innovate, DIA’s 48th Annual Meeting, is the medical product and health care industries’ largest multidisciplinary event, and brings together a global network of 7,500 professionals to develop safe and effective medical products.

DIA recognizes the innovative seed and early-stage start-up companies that are impacting these industries and we welcome your participation at this year’s event.

Eight entrepreneurs will be given the opportunity to showcase their work at this year’s DIA Annual Meeting.

These entrepreneurs will receive complete and total access within the DIA Annual Meeting Exhibit Hall (which features 500+ exhibiting companies from all around the world) and a small dedicated area (including internet hookup) for a live demonstration or presentation of their innovative product.

For more information, please click on the link below:

http://www.diahome.org/productfiles/27170/12001_EntrepreneurApplication.pdf

Trusted Identities for Cloud Collaboration, June 24, 2012

DIA 2012 Collaborate to Innovate

48th Annual Meeting
June 24-28, 2012
Philadelphia, PA
Pennsylvania Convention Center

Trusted Identities for Cloud Collaboration: How Standards Accelerate Collaboration In The Cloud
Sunday, June 24, 2012
9:00 AM - 6:30 PM
Pennsylvania Convention Center

This seminal conference co-hosted by DIA and SAFE-BioPharma® provides a deep dive into the use of standardized identity trust to improve speed, cost, and efficiency in cloud collaboration.

Featured Topics:

• ePatient trial data entry using trusted digital identities and iPads
• Cloud-based clinical trial initiation
• ePrescribing
• Digital signing and exchange of adverse events
• eSubmissions
• Electronic laboratory notebooks

Register Today

Program Chairperson

Mollie Shields-Uehling
President and CEO
SAFE-BioPharma^®

Learning Objectives:

Attendees of this meeting will be able to

• Describe standards-based interoperable digital identities and the essential uses in biopharmaceuticals and healthcare
• Explain benefits and obstacles associated with introducing and using this technology
• Identify the spectrum of current and future applications for standards-based interoperable digital identities and digital signatures
• Discuss the practical use of standards-based interoperable digital identities and digital signatures within organizations.

Please click for Agenda

Registration Fees

$755 includes access to "Trusted Identities for Cloud ollaboration," refreshment breaks, and lunch.
Save $200 when you register for both "Trusted Identities for Cloud Collaboration" and DIA 2012.*
Register Today
Application & Contract for Table Top Display
* Both purchases must be made at the same time to receive the discount.

About SAFE-BioPharma^®

SAFE-BioPharma^® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.

Homepage

Email A Friend
Printer Friendly

© 2011 DIA | Home | diahome.org | Site Map | Contact Us | Disclaimer | Privacy Policy